LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?

<p>Abstract</p> <p>Background</p> <p>Investigation of the expression of an intestinal stem cell marker in esophageal adenocarcinomas (EAC) with and without Barrett's Esophagus (BE), with respect to a cancer stem cell (CSC) hypothesis.</p> <p>Materials a...

Full description

Bibliographic Details
Main Authors: Otto Christoph, Stuermer Luisa, Reiber Christoph, Lazariotou Maria, Kircher Stefan, von Rahden Burkhard HA, Germer Christoph T, Grimm Martin
Format: Article
Language:English
Published: BMC 2011-02-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/30/1/23
id doaj-4a577de024c74a7fb15c96e26967abd7
record_format Article
spelling doaj-4a577de024c74a7fb15c96e26967abd72020-11-24T23:57:14ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662011-02-013012310.1186/1756-9966-30-23LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?Otto ChristophStuermer LuisaReiber ChristophLazariotou MariaKircher Stefanvon Rahden Burkhard HAGermer Christoph TGrimm Martin<p>Abstract</p> <p>Background</p> <p>Investigation of the expression of an intestinal stem cell marker in esophageal adenocarcinomas (EAC) with and without Barrett's Esophagus (BE), with respect to a cancer stem cell (CSC) hypothesis.</p> <p>Materials and methods</p> <p>Expression of a putative intestinal stem cell marker LgR5 was analyzed in esophageal cancer specimen (n = 70: 41 EAC with BE, 19 EAC without BE, and n = 10 esophageal squamous-cell carcinomas, ESCC) and in the adenocarcinoma cell line OE-33. Ki-67 and Cdx-2 were co-labelled with LgR5 in double staining experiments. Immunhistochemical expression results were confirmed by RT-PCR and correlated with tumor stage and five-year survival rates.</p> <p>Results</p> <p>LgR5was found expressed in 35 of 41 (85%) EAC with BE and in 16 of 19 (81%) EAC without BE. By contrast, LgR5 was not found to be expressed in ESCC. Quantification of immunolabeling showed 15% LgR5+ cells in EAC with BE, 32% LgR5+ cells in adjacent BE and 13% in EAC without BE. Immunofluorescence double staining experiments with LgR5 and Ki-67 revealed a subpopulation (~5%) of proliferating LgR+/Ki-67+ cells. On mRNA-level, expression of LgR5 was higher in BE in comparison to EAC (p = 0.0159). High levels of LgR5 expression in BE associated EAC were associated with poorer survival in univariate analysis.</p> <p>Conclusion</p> <p>The stem cell marker LgR5 is expressed in EAC, irrespective of association with BE, and appears to have negative impact on survival. The subset of proliferating LgR5+ cells (<5%) might resemble rapidly cycling CSCs, which needs to be substantiated in further investigations.</p> http://www.jeccr.com/content/30/1/23
collection DOAJ
language English
format Article
sources DOAJ
author Otto Christoph
Stuermer Luisa
Reiber Christoph
Lazariotou Maria
Kircher Stefan
von Rahden Burkhard HA
Germer Christoph T
Grimm Martin
spellingShingle Otto Christoph
Stuermer Luisa
Reiber Christoph
Lazariotou Maria
Kircher Stefan
von Rahden Burkhard HA
Germer Christoph T
Grimm Martin
LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?
Journal of Experimental & Clinical Cancer Research
author_facet Otto Christoph
Stuermer Luisa
Reiber Christoph
Lazariotou Maria
Kircher Stefan
von Rahden Burkhard HA
Germer Christoph T
Grimm Martin
author_sort Otto Christoph
title LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?
title_short LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?
title_full LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?
title_fullStr LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?
title_full_unstemmed LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus?
title_sort lgr5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without barrett's esophagus?
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2011-02-01
description <p>Abstract</p> <p>Background</p> <p>Investigation of the expression of an intestinal stem cell marker in esophageal adenocarcinomas (EAC) with and without Barrett's Esophagus (BE), with respect to a cancer stem cell (CSC) hypothesis.</p> <p>Materials and methods</p> <p>Expression of a putative intestinal stem cell marker LgR5 was analyzed in esophageal cancer specimen (n = 70: 41 EAC with BE, 19 EAC without BE, and n = 10 esophageal squamous-cell carcinomas, ESCC) and in the adenocarcinoma cell line OE-33. Ki-67 and Cdx-2 were co-labelled with LgR5 in double staining experiments. Immunhistochemical expression results were confirmed by RT-PCR and correlated with tumor stage and five-year survival rates.</p> <p>Results</p> <p>LgR5was found expressed in 35 of 41 (85%) EAC with BE and in 16 of 19 (81%) EAC without BE. By contrast, LgR5 was not found to be expressed in ESCC. Quantification of immunolabeling showed 15% LgR5+ cells in EAC with BE, 32% LgR5+ cells in adjacent BE and 13% in EAC without BE. Immunofluorescence double staining experiments with LgR5 and Ki-67 revealed a subpopulation (~5%) of proliferating LgR+/Ki-67+ cells. On mRNA-level, expression of LgR5 was higher in BE in comparison to EAC (p = 0.0159). High levels of LgR5 expression in BE associated EAC were associated with poorer survival in univariate analysis.</p> <p>Conclusion</p> <p>The stem cell marker LgR5 is expressed in EAC, irrespective of association with BE, and appears to have negative impact on survival. The subset of proliferating LgR5+ cells (<5%) might resemble rapidly cycling CSCs, which needs to be substantiated in further investigations.</p>
url http://www.jeccr.com/content/30/1/23
work_keys_str_mv AT ottochristoph lgr5expressionandcancerstemcellhypothesiscluetodefinethetrueoriginofesophagealadenocarcinomaswithandwithoutbarrettsesophagus
AT stuermerluisa lgr5expressionandcancerstemcellhypothesiscluetodefinethetrueoriginofesophagealadenocarcinomaswithandwithoutbarrettsesophagus
AT reiberchristoph lgr5expressionandcancerstemcellhypothesiscluetodefinethetrueoriginofesophagealadenocarcinomaswithandwithoutbarrettsesophagus
AT lazariotoumaria lgr5expressionandcancerstemcellhypothesiscluetodefinethetrueoriginofesophagealadenocarcinomaswithandwithoutbarrettsesophagus
AT kircherstefan lgr5expressionandcancerstemcellhypothesiscluetodefinethetrueoriginofesophagealadenocarcinomaswithandwithoutbarrettsesophagus
AT vonrahdenburkhardha lgr5expressionandcancerstemcellhypothesiscluetodefinethetrueoriginofesophagealadenocarcinomaswithandwithoutbarrettsesophagus
AT germerchristopht lgr5expressionandcancerstemcellhypothesiscluetodefinethetrueoriginofesophagealadenocarcinomaswithandwithoutbarrettsesophagus
AT grimmmartin lgr5expressionandcancerstemcellhypothesiscluetodefinethetrueoriginofesophagealadenocarcinomaswithandwithoutbarrettsesophagus
_version_ 1725454956375310336